Carastock.

Cara Therapeutics Inc’s ( CARA) price is currently down 34.15% so far this month. During the month of March, Cara Therapeutics Inc’s stock price has reached a high of $10.39 and a low of $6.58. Over the last year, Cara Therapeutics Inc has hit prices as high as $13.97 and as low as $7.40. Year to date, Cara Therapeutics Inc’s stock is ...Dec 1, 2023 · According to the issued ratings of 6 analysts in the last year, the consensus rating for Cara Therapeutics stock is Moderate Buy based on the current 1 sell rating, 1 hold rating and 4 buy ratings for CARA. The average twelve-month price prediction for Cara Therapeutics is $15.86 with a high price target of $25.00 and a low price target of $4.00. 6 brokerages have issued 1-year price targets for Cara Therapeutics' stock. Their CARA share price targets range from $4.00 to $25.00. On average, they expect the …Cara Therapeutics Inc (CARA) stock is down -4.28% while the S&P 500 has gained 1.3% as of 12:31 PM on Wednesday, Apr 27. CARA is down -$0.45 from the previous closing price of $10.51 on volume of 212,841 shares. Over the past year the S&P 500 has gained 1.02% while CARA is down -61.46%. CARA lost -$1.74 per share in the over the …

Cara Therapeutics Inc stock is down -23.46% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives CARA stock a score of 75 out of a possible 100.. That rank is mainly influenced by a fundamental score of 84. In addition to the average rating from Wall …Cara Therapeutic stock price live 0.97, this page displays NASDAQ CARA stock exchange data. View the CARA premarket stock price ahead of the market session or assess the after hours quote.

Thinking of buying or selling Cara Therapeutic stock that’s listed in a currency different from your local one? Use our international stock ticker to check and convert stocks and shares easily in any currency you need.Dec 1, 2023 · 6 brokerages have issued 1-year price targets for Cara Therapeutics' stock. Their CARA share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $15.86 in the next twelve months. This suggests a possible upside of 1,396.0% from the stock's current price.

Find out the direct holders, institutional holders and mutual fund holders for Cara Therapeutics, Inc. (CARA). Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), MoonLake Immunotherapeutics (MLTX) and Cara Therapeutics (CARA) November 14, 2023TipRanks. Cara shares ‘highly disconnected ... Mar 10, 2023 · As of March 10, 2023, 4:00 PM CST, Cara Therapeutics Inc’s stock price was $6.06. Cara Therapeutics Inc is down 5.16% from its previous closing price of $6.39. During the last market session, Cara Therapeutics Inc’s stock traded between $6.24 and $6.71. Currently, there are 53.76 million shares of Cara Therapeutics Inc stock available for ... The 39 rating InvestorsObserver gives to Cara Therapeutics Inc ( CARA) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 41 percent of stocks in the Biotechnology industry, CARA’s 39 overall rating means the stock scores better than 39 percent of all stocks. CARA has an Overall Score of 39.Browse Getty Images' premium collection of high-quality, authentic Cara stock photos, royalty-free images, and pictures. Cara stock photos are available in ...

CARA's current price target is $15.86. Learn why top analysts are making this stock forecast for Cara Therapeutics at MarketBeat.

Nov 27, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...

Complete Cara Therapeutics Inc. stock information by Barron's. View real-time CARA stock price and news, along with industry-best analysis.Following the downgrade, the current consensus from Cara Therapeutics' eight analysts is for revenues of US$53m in 2023 which - if met - would reflect a sizeable 27% increase on its sales over the ...12 thg 2, 2014 ... Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, ...Over the last four quarters, the company has surpassed consensus EPS estimates two times. Cara, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $3.26 ...Find out the direct holders, institutional holders and mutual fund holders for Cara Therapeutics, Inc. (CARA).

Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...Thinking of buying or selling Cara Therapeutic stock that’s listed in a currency different from your local one? Use our international stock ticker to check and convert stocks and shares easily in any currency you need.Aug 24, 2021 · CARA stock was up 2.8% as of Tuesday afternoon. On the date of publication, Nick Clarkson did not have (either directly or indirectly) any positions in the securities mentioned in this article. Cara Therapeutics Reports Second Quarter 2023 Financial Results. – 2Q23 total revenue of $6.9M including collaborative revenue of $5.4M from the Company’s share of profit of KORSUVA ® (difelikefalin) injection – – Demand for KORSUVA injection accelerating with 46% increase in vial orders quarter to quarter – – 2024 ESRD PPS ...6 brokerages have issued 1-year price targets for Cara Therapeutics' stock. Their CARA share price targets range from $4.00 to $25.00. On average, they expect the …

Get the latest Cara Therapeutics Inc. (CARA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Discover historical prices for CARA stock on Yahoo Finance. View daily, …

Cara Therapeutics stock was originally listed at a price of $12.91 in Jan 31, 2014. If you had invested in Cara Therapeutics stock at $12.91, your return over the last 9 years would have been -91.32%, for an annualized return of -23.79% (not including any dividends or dividend reinvestments). How much is Cara Therapeutics's stock price per ...View the latest Cara Therapeutics Inc. (CARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. eToro. Buy Stocks. On eToro’s Website. Get millions of investment ideas on eToro with the power of social investing. Explore over 2,500 stocks. Buy in bulk, or invest in fractional shares. eToro ...Untuk menyimpulkan bahasan kita kali ini, ada 8 tips yang bisa anda gunakan untuk mengoptimalkan safety stock anda: Pertama, hindari angka safety stock yang fix. Masalahnya, saat anda menetapkan angka yang fix sebagai safety stock anda, misal 1000 unit, sales akan fluktuatif tapi safety stock anda ngga.The firm currently boasts a market capitalization value of $187.83 million alongside a price-earnings ratio of -2.23 and beta of 0.87. Nonetheless, with exponential growth attainable through various regulatory approvals, the research-based biopharmaceutical company appears primed to deliver cutting-edge solutions that …Cara Therapeutics stock news, updates & related news. Find out why Cara Therapeutics's (CARA) news sentiment is 13.38% more negative in relation to stocks ...Feb 12, 2014 · Post #2,000. Item 8.01 Other Information. As previously disclosed, on August 23, 2021, Cara Therapeutics, Inc. (“Cara”) received approval of its New Drug Application for KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients from the U.S. Food and Drug Administration (the “Approval Milestone”). Mar 21, 2023 · Cara Therapeutics Inc (CARA) stock is trading at $5.51 as of 3:36 PM on Tuesday, Mar 21, a gain of $0.21, or 3.96% from the previous closing price of $5.30. The stock has traded between $5.31 and $5.53 so far today. Volume today is below average.

Explore new charts. Discover historical prices for CARA stock on Yahoo Finance. View daily, weekly or monthly format back to when Cara Therapeutics, Inc. stock was issued.

Cara Therapeutics Inc (CARA) stock is trading at $6.33 as of 3:12 PM on Thursday, Mar 9, a drop of -$0.09, or -1.33% from the previous closing price of $6.41. Volume today is more active than usual. So far 850,368 shares have traded compared to average volume of 621,904 shares. The stock has traded between $6.24 and $6.71 so …

Apr 24, 2023 · Cara Therapeutics' current financial performance and market outlook do not paint an encouraging picture for investors. Find out why CARA stock is a Sell. The average price recommended by analysts for Cara Therapeutics Inc (CARA) is $10.29, which is $9.33 above the current market price. The public float for CARA is 46.23M and currently, short sellers hold a 6.42% of that float. On November 24, 2023, CARA’s average trading volume was 599.48K shares. Top 5 EV Tech Stocks to Buy for …The current Cara Therapeutics [ CARA] share price is $1.09. The Score for CARA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal. CARA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.Complete Cara Therapeutics Inc. stock information by Barron's. View real-time CARA stock price and news, along with industry-best analysis. CARA stock was up 2.8% as of Tuesday afternoon. On the date of publication, Nick Clarkson did not have (either directly or indirectly) any positions in the securities mentioned in this article.Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.Apr 24, 2023 · Cara Therapeutics' current financial performance and market outlook do not paint an encouraging picture for investors. Find out why CARA stock is a Sell. View the latest Cara Therapeutics Inc. (CARA) stock price, news, historical charts, analyst ratings and financial information from WSJ.View the latest Cara Therapeutics Inc. (CARA) stock price, news, historical charts, analyst ratings and financial information from WSJ.The firm currently boasts a market capitalization value of $187.83 million alongside a price-earnings ratio of -2.23 and beta of 0.87. Nonetheless, with exponential growth attainable through various regulatory approvals, the research-based biopharmaceutical company appears primed to deliver cutting-edge solutions that resonate in today’s ...Treasury Stock: Pengertian, Tujuan, Metode Pencatatan, dan Contoh Praktis. 2 September 2023 oleh Wadiyo, S.E. Treasury Stock adalah salah satu model yang digunakan perusahaan untuk mengelola modal saham yang dimiliki. Modal pendirian perusahaan yang berbentuk perseroan terbatas (PT) diperoleh dari penjualan saham.

Complete Cara Therapeutics Inc. stock information by Barron's. View real-time CARA stock price and news, along with industry-best analysis.In 2022, CARA's revenue was $41.87 million, an increase of 81.81% compared to the previous year's $23.03 million. Losses were -$85.47 million, -3.35% less than ...Feb 12, 2014 · Post #2,000. Item 8.01 Other Information. As previously disclosed, on August 23, 2021, Cara Therapeutics, Inc. (“Cara”) received approval of its New Drug Application for KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients from the U.S. Food and Drug Administration (the “Approval Milestone”). Instagram:https://instagram. best portfolio management software for individualsbest t rowe price money market fundaunto zonelfrix Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties ... movers stockmandt home mortgage Complete Cara Therapeutics Inc. stock information by Barron's. View real-time CARA stock price and news, along with industry-best analysis.Dec 1, 2023 · Who is on Cara Therapeutics's Insider Roster? The list of insiders at Cara Therapeutics includes Christopher Posner, Derek T Chalmers, Frederique Ph.D. Menzaghi, Jeffrey L Ives, Joana Goncalves, Martin Vogelbaum, Scott Terrillion, and Thomas Charles Reilly. Learn more on insiders at CARA. how to choose forex broker What's Happening with CARA Stock Today Cara Therapeutics Inc (CARA) stock is down -4.28% while the S&P 500 has gained 1.3% as of 12:31 PM on Wednesday, Apr 27. CARA is down -$0.45 from the previous closing price of $10.51 on volume of 212,841 shares. Over the past year the S&P 500 has gained 1.02% while CARA is down -61.46%.May 25, 2023 · Simply Wall St. May 25, 2023 at 6:40 AM · 3 min read. You may think that with a price-to-sales (or "P/S") ratio of 4.4x Cara Therapeutics, Inc. ( NASDAQ:CARA) is a stock to potentially avoid ...